FLUO Share Price Performance
SEK 41.80
6.45 (18.25%)
Price SEK 41.80
Share PriceSEK 41.80
FluoGuide A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
FLUO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
FluoGuide A/S Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 27, 2025
- -2.35
- 100.00%
- 5,846.35%
- 370.9%
About FLUO
- Founded
- 2018
- Employees
- 8
- CEO
- WebsiteView website
FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
